Results 271 to 280 of about 425,098 (322)

Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections. [PDF]

Microbiol Spectr
Hintzen JCJ, Rahimi S, Tietze D, Zhang J, Mehra P, Mijakovic I, Tietze AA.   +6 more
europepmc   +1 more source

A Culture-Free Lipidomics-Based Screening Test for Uropathogens. [PDF]

Clin Chem
Nartey LK, Pekcan M, Liu J, Yuen V, Kibsey P, Ernst RK, Goodlett DR, Chen MX.   +7 more
europepmc   +1 more source

Epidemiological trends in bacterial resistance in diabetic foot infections across the COVID-19 timeline: a retrospective analysis. [PDF]

IJID Reg
Giarritiello F, Deflorio L, De La Motte LR, Sommese C, Benedetti S, Brocco E, Drago L.   +6 more
europepmc   +1 more source

Tetracycline Resistance Pattern Among Lymphatic Filariasis-Hyperendemic Communities in Southern Ghana: A Mixed-Method Approach. [PDF]

Health Sci Rep
Osei-Poku P, Wilson MB, Shardow ALK, Abakah A, Amewu EKA, Kyerewaa CA, Larbi A, Kwarteng A.   +7 more
europepmc   +1 more source

Delafloxacin: what does a new fluoroquinolone offer? [PDF]

Rev Esp Quimioter
Cercenado E, Murillo O.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of gram-positive bacterial infections in patients with cancer

Leukemia & Lymphoma, 2011
Bacterial infections, particularly those due to gram-positive bacteria, continue to predominate in patients with cancer. Coagulase-negative and coagulase-positive staphylococci and enterococci remain as common pathogenic microorganisms. Clostridium difficile has emerged as a significant pathogen.
Christos I, Kosmidis, Pranatharthi H, Chandrasekar   +1 more
  +5 more sources